Clinical Allergy, 1975, Volume 5, pages 285-290
Intranasal betamethasone valerate in the treatment of seasonal rhinitis
G. J. ARCHER,* A. K. THOMAS and S. M. HARDING Department of Respiratory Medicine, Leeds University {St James's) Hospital, Leeds Clinical Research Unit, Glaxo Laboratories Ltd, Greenford
Summary
Betamethasone valerate aerosol given in doses of 100/ig into each nostril twice daily was compared with a placebo in a double-blind, cross-over trial involving thirty patients with seasonal rhinitis. Patients recorded symptoms of eye irritation and watering, sneezing, rhinorrhoea, and nasal blockage, on a diary card. Analysis of the symptom scores showed that nasal symptoms were significantly better on betamethasone valerate than on placebo (P
Intranasal betamethasone valerate in the treatment of seasonal rhinitis
G. J. ARCHER,* A. K. THOMAS and S. M. HARDING Department of Respiratory Medicine, Leeds University {St James's) Hospital, Leeds Clinical Research Unit, Glaxo Laboratories Ltd, Greenford
Summary
Betamethasone valerate aerosol given in doses of 100/ig into each nostril twice daily was compared with a placebo in a double-blind, cross-over trial involving thirty patients with seasonal rhinitis. Patients recorded symptoms of eye irritation and watering, sneezing, rhinorrhoea, and nasal blockage, on a diary card. Analysis of the symptom scores showed that nasal symptoms were significantly better on betamethasone valerate than on placebo (P
